Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.37, $0.07 better than the analyst estimate of $0.30. Revenue for the quarter came in at $466.6 million versus the consensus estimate of $451.7 million.

GUIDANCE:

Bruker sees FY2018 EPS of $1.36-$140.00, versus the consensus of $1.37.

For FY 2018, the Company now expects year-over-year revenue growth of 6.5% to 7.0%, including the following updates compared to our previous outlook as issued on August 2, 2018:

• organic revenue growth of 3.5% to 4.0%,
• growth from acquisitions of approximately 1.5%, and
• a foreign currency revenue tailwind of approximately 1.5%.

For earnings history and earnings-related data on Bruker (BRKR) click here.